Document Detail


Ovarian stimulation: from basic science to clinical application.
MedLine Citation:
PMID:  12537786     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Treatment for infertility, including ovarian stimulation, was first introduced almost 100 years ago. At this time, radiation therapy became an established treatment, and it was only some decades later that the problem of radiation-induced cancer emerged. Non-human gonadotrophins, such as pregnant mare serum gonadotrophin (PMSG), and human pituitary gonadotrophins (HPG), were commonly used for hormonal stimulation procedures. However, use of PMSG led to antibody formation, and it was therefore only useful for the first treatment cycle. HPG produced good results, but its use came to an end in the late 1980s when it was linked to the development of Creutzfeldt-Jakob disease. The first hormonal product from human menopausal urine to be used was human menopausal gonadotrophin (HMG), followed later by purified preparations of this product. All of these preparations contained a high percentage of unknown urinary proteins, which interfered with batch-to-batch consistency. This changed with the introduction of recombinant gonadotrophins, produced from an immortalized/standardized mammalian cell line (CHO). More recent developments include the introduction of long-acting gonadotrophin formulations. The development of gonadotrophin-releasing hormone (GnRH) analogues and more recently the use of GnRH antagonists has helped to improve ovarian stimulation protocols by optimizing their efficacy, and making them easier to administer.
Authors:
Michael Ludwig; Ricardo E Felberbaum; Klaus Diedrich; Bruno Lunenfeld
Related Documents :
773806 - Therapy-orientated diagnosis of secondary amenorrhoea.
3106106 - The outcome of continued treatment of luteinizing hormone-surged cycles in in vitro fer...
2555076 - Comparison of endocrinological stress response associated with transvaginal ultrasound-...
19090826 - Effects of superovulation with ofsh and norgestomet/gnrh-controlled release of the lh s...
4073676 - Body composition in the cirrhotic patient with ascites: assessment of total exchangeabl...
15718276 - Proopiomelanocortin processing in the anterior pituitary of the ovine fetus after lesio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  5 Suppl 1     ISSN:  1472-6483     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2002  
Date Detail:
Created Date:  2013-04-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  73-86     Citation Subset:  IM    
Affiliation:
Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, 23538 Lübeck, Germany. Ludwig_M@t-online.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
Next Document:  Altruism in assisted reproductive technologies.